Correlation between Anti-Mullerian Hormone Levels and Sexual Dysfunction in Infertile Women
Asian Research Journal of Gynaecology and Obstetrics,
Aim: The purpose of the study was to evaluate the correlation between Anti-Mullerian hormone (AMH) levels and sexual dysfunction in infertile women.
Methods: This prospective cross-sectional study was done on 558 infertile women. The participants were divided into three different AMH groups i.e. first AMH group (poor responder with ≤3 oocytes), second AMH group (normoresponder with 4–9 oocytes), and third AMH group (high responder with ≥10 oocytes). The values of the total Female Sexual Function Index (FSFI) variable were divided into three FSFI levels: level 1 (below 23), level 2 (between 23 and 29), and Level 3 (above 30). The participants were divided into two groups: the first group with normal weight (BMI<25) and the second group with overweight (25<BMI<30). The FSFI questionnaire as a standardized and validated self-report was applied for measurement of the female sexual dysfunction.
Results: The mean age of the participants was 30.14 years and the mean BMI was 24.81. 64.87% of the participants had normal weight and 35.13% had overweight. Regarding the total FSFI levels, 55.4% of the participants are at level 1, 42.3% at level 2, and 2.3% at level 3. The first AMH group had a mean of 0.58±0.27, the second AMH group had a mean of 2.38±0.89, and the third group had a mean of 6.42±1.58. There was a significant difference among the three AMH groups in terms of all total FSFI subdomains. The participants at total FSFI level 1 had p-value=0.00, those at level 2 had p-value=0.00 and those at Level 3 had p-value=0.005.
Conclusion: Sexual dysfunction is reversely correlated with AMH. The participants with overweight had higher AMH value. To overcome female sexual dysfunction among infertile women, it is necessary to have sexual counseling, determine the factors affecting sexual dysfunction, and provide appropriate treatment.
- Anti-mullerian hormone
- body mass index
- female sexual function index
- sexual dysfunction.
How to Cite
Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in “normal” couples. N Engl J Med. 1978; 299:111-115.
Rosen RC, Taylor JF, Leiblum SR, Bachmann GA.Prevalence of sexual dysfunction in women: Results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther. 1993;19:171-188.
Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: A critical review of the empirical literature. Arch Sex Behav. 1990;19:389-408.
Salonia A, Munarriz R, Naspro R. Women's sexual dysfunction: A patho-physiological review. Br J Urol. 2004;93: 1156–64.
Burri A, Spector T. Recent and lifelong sexual dysfunction in a female UK population sample: Prevalence and risk factors. J Sex Med 2011;8(9):2420–30.
Arrington R, Cofrancesco J, Wu AW. Questionnaires to measure the sexual quality of life. Quality of Life Research. 2004;13:1643–1658.
Mölleken D, Richter-Appelt H, Stodieck S. Influence of personality on sexual quality of life in epilepsy. Epileptic Disord. 2010;12: 125–132.
Cwikel J, Gidron Y, Sheiner E. Psychological interactions with infertility among women. Eur J Obstet Gynecol Reprod Biol. 2004;117:126–31.
OB Damti, O Sarid, E Sheiner, et al. Stress and distress in infertility among women. Harefuah. 2008;147:256–60.
A Drosdzol, V Skrzypulec. Depression and anxiety among Polish infertile couples--an evaluative prevalence study. J Psychosom Obstet Gynaecol. 2009;30:11–20.
Cousineau T, Domar A. Psychological impact of infertility. Best Pract Res Clin Obstet Gynaeco. 2007;21:293–308.
Shindel AW, Nelson CJ, Naughton CK, Ohebshalom M, Mulhall JP. Sexual function and quality of life in the male partner of infertile couples: prevalence and correlates of dysfunction. J Urol. 2008;179: 1056–9.
Carter J, Applegarth L, Josephs L, Grill E, Baser RE, Rosenwaks Z. A cross-sectional cohort study of infertile women awaiting oocyte donation: The emotional, sexual, and quality-of-life impact. Fertil Steril. 2011;95:711–6.
Aydın S, Kurt N, Mandel S, et al. Female sexual distress in infertile Turkish women. Turkish Journal of Obstetrics and Gynecology. 2015;12(4):205-210.
Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, et al. Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986; 45:685–98.
Broer SL, Mol BW, Hendriks D, Broekmans FJ. Broekmans The role of antimullerian hormone in prediction of outcome after IVF:comparison with the antral follicle count. Fertil Steril. 2009;91:705-14.
Buyuk E, Seifer DB, Illions E, Grazi RV, Lieman H. Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve. Fertil Steril. 2011; 95:2364–8.
Mosher WD. Infertility trends among U.S. couples: 1965-1976. Fam Plann Perspect 1982;14:22-7.
Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC, Strauss JF 3rd. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril. 2007;87:101–6.
Moslehi N, Shab-Bidar S, Ramezani Tehrani F, Mirmiran P, Azizi F. Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis. Menopause. 2018;25: 1046–55.
Pal L, Bevilacqua K, Zeitlian G, et al. Implications of Diminished Ovarian Reserve (DOR) extend well beyond reproductive concerns. Menopause. 2008;15:1086-94.
De Almeida DM1, Benetti-Pinto CL, Makuch MY. Sexual function of women with premature ovarian failure. Menopause. 2011;18:262-6.
Van der Stege JG, Groen H, van Zadelhoff SJ, Lambalk CB, Braat DD, van Kasteren YM, van Santbrink EJ, Apperloo MJ, Schultz WC, Hoek A. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause. 20081;15(1): 23-31.
Graziottin A, Basson R. Sexual dysfunction in women with premature menopause. Menopause 2004;11:766-77.
Shindel AW, Nelson CJ, Naughton CK, Ohebshalom M, Mulhall JP. Sexual function and quality of life in the male partner of infertile couples: prevalence and correlates of dysfunction. J Urol. 2008; 179:1056–9.
Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 2011;95:170-5.
Cui L, Qin Y, Gao X, et al. Antimullerian hormone: Correlation with age and androgenic and metabolic factors in women from birth to postmenopause. Fertil Steril. 2016;105(2):481–5.
Karli P., Ozdemir A. Sexual dysfunction in in-vitro fertilization (IVF) patients and the effect of ovarian reserve on sexual dysfunction. Annals of Medical Research. 2019;06:350.
Palacios S, Castaño R, Grazziotin A. Epidemiology of female sexual dysfunction. Maturitas. 2009;63:119-23.
Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: Prevalence and correlates. Obstet Gynecol 2008;112:970-8.
Abstract View: 1015 times
PDF Download: 1923 times